Cognitive Impairment / Memory Dysfunction (Medication-Induced) Secondary to Chronic Pain Condition (Treated with Gabapentin/Pregabalin)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Cognitive Impairment / Memory Dysfunction (Medication-Induced) is a documented secondary pairing for Chronic Pain Condition (Treated with Gabapentin/Pregabalin) with moderate medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Cognitive Impairment / Memory Dysfunction (Medication-Induced) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Chronic Pain Condition (Treated with Gabapentin/Pregabalin) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Cognitive Impairment / Memory Dysfunction (Medication-Induced) as secondary to Chronic Pain Condition (Treated with Gabapentin/Pregabalin) is rated moderate. Gabapentin and pregabalin, widely prescribed for service-connected neuropathic pain, produce cognitive impairment through GABAergic and calcium channel modulation in the central nervous system. These medications bind voltage-gated calcium channels (alpha-2-delta subunit), reducing excitatory neurotransmitter release in the hippocampus and prefrontal cortex — regions critical for memory and executive function. Studies demonstrate dose-dependent cognitive impairment: at standard neuropathic pain doses (gabapentin 1800-3600mg/day, pregabalin 300-600mg/day), patients show measurable deficits in verbal memory, processing speed, and attention. The "gabapentin fog" is well-recognized clinically and can impair occupational functioning independently of the underlying pain condition.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.